Piper Sandler & Co. Aytu Biopharma, Inc Transaction History

Piper Sandler & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.08 - $1.55 $53,557 - $76,864	-49,590 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.35 - $2.95 $66,946 - $146,290	49,590 New	49,590 $297,000
Q1 2021 May 14, 2021	SELL	$6.23 - $9.88 $308,945 - $489,949	-49,590 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$5.98 - $13.5 $296,548 - $669,465	49,590 New	49,590 $297,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $134M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Piper Sandler & Co., based on Form 13F filings with the SEC.

Stay updated on Piper Sandler & Co. with notifications on news.